Article Information
History
- September 30, 2020.
Article Versions
- You are currently viewing Version 1 of this article (September 30, 2020 - 16:00).
- Version 2 (October 23, 2020 - 10:48).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Antonin Bal1,2,
- Bruno Pozzetto3,4,
- Mary-Anne Trabaud1,
- Vanessa Escuret1,2,
- Muriel Rabilloud5,6,
- Carole Langlois-Jacques5,6,
- Adèle Paul7,8,
- Nicolas Guibert7,8,
- Constance D’Aubarede7,8,
- Amélie Massardier-Pilonchery7,8,
- André Boibieux9,
- Florence Morfin1,2,
- Virginie Pitiot8,
- François Gueyffier6,10,
- Bruno Lina1,2,
- Jean-Baptiste Fassier7,8,
- Sophie Trouillet-Assant2,*,
- COVID SER STUDY GROUP
- 1Laboratoire de Virologie, Institut des Agents Infectieux, Laboratoire associé au Centre National de Référence des virus des infections respiratoires, Hospices Civils de Lyon, Lyon, France
- 2CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France
- 3GIMAP EA 3064 (Groupe Immunité des Muqueuses et Agents Pathogènes), Université Jean Monnet, Lyon University, Saint-Etienne, France
- 4Laboratory of Infectious Agents and Hygiene, University Hospital of Saint-Etienne, Saint-Etienne, France
- 5Université de Lyon, F-69000, Lyon, France; Université Lyon 1, F-69100, Villeurbanne, France; Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, F-69003, Lyon, France
- 6CNRS, UMR 5558, University of Lyon, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, 69100, Villeurbanne, France.
- 7Lyon University, Université Claude Bernard Lyon1, Ifsttar, UMRESTTE, UMR T_9405, 8 avenue Rockefeller Lyon, France
- 8Occupational Health and Medicine Department, Hospices Civils de Lyon, Lyon, France.
- 9Infectious Diseases Department, Hospices Civils de Lyon, Lyon, France.
- 10Pharmacotoxicology Department, Hospices Civils de Lyon, Lyon, France.
- ↵*Corresponding author:
Dr Sophie Trouillet-Assant, Ph.D, Hospices Civils de Lyon, France, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm,U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69007, Lyon, France, Phone: + 33 (0)472678780 Email: sophie.assant{at}chu-lyon.fr
Posted September 30, 2020.
Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of mild COVID-19 patients: sensitivity, specificity and association with virus neutralization test
